The Veteran's claim for an initial rating in excess of 0 percent for bilateral onychomycosis of the toes is being remanded due to a need for clarification regarding whether oral Lamisil, a treatment previously prescribed for his condition, qualifies as systemic therapy.
The deciding factor: The Board requires additional medical opinion to determine if oral Lamisil qualifies as systemic therapy based on its effects and side effects compared to corticosteroids or other immunosuppressive drugs.
- Claimed conditions
- onychomycosis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- August 7, 2019
- Citation
- 19161171
Veterans Law Judge
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 19161171.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for an initial compensable disability rating for onychomycosis was denied as the condition did not require treatment and covered less than 5% of his body. The Board also remanded issues regarding service connection for left ear hearing loss and entitlement to a compensable disability rating for right ear hearing loss.
- Remanded (sent back)
The Veteran's claims for increased ratings of his service-connected toenail disabilities and service connection for lumbosacral strain, joint pain, and an acquired psychiatric disorder are being remanded due to the need for further development.
- Dismissed
The Veteran withdrew his appeals for all the listed conditions in April 2024 and March 2025, thus dismissing the appeal.
- Remanded (sent back)
The Veteran's onychomycosis is rated under the old criteria and remanded for further development to determine if systemic therapy, such as fluconazole, is similar to corticosteroids or immunosuppressive drugs.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.